HIV ATLAS

Social Media for HIV, TB & Malaria!

English Afrikaans Albanian Arabic Armenian Azerbaijani Basque Belarusian Bulgarian Catalan Chinese (Simplified) Chinese (Traditional) Croatian Czech Danish Dutch Estonian Filipino Finnish French Galician Georgian German Greek Haitian Creole Hebrew Hindi Hungarian Icelandic Indonesian Irish Italian Japanese Korean Latvian Lithuanian Macedonian Malay Maltese Norwegian Persian Polish Portuguese Romanian Russian Serbian Slovak Slovenian Spanish Swahili Swedish Thai Turkish Ukrainian Urdu Vietnamese Welsh Yiddish

Development of antitubercular compounds based on a 4-quinolylhydrazone scaffold. Further structure-activity relationship studies

Development of antitubercular compounds based on a 4-quinolylhydrazone scaffold. Further structure-activity relationship studies. - Related Articles
Development of antitubercular compounds based on a 4-quinolylhydrazone scaffold. Further structure-activity relationship studies.
Bioorg Med Chem. 2009 Jun 27;
Authors: Gemma S, Savini L, Altarelli M, Tripaldi P, Chiasserini L, Coccone SS, Kumar V, Camodeca C, Campiani G, Novellino E, Clarizio S, Delogu G, Butini S
A series of 4-quinolylhydrazones was synthesized and tested in vitro against Mycobacterium tuberculosis. At a concentration of 6.25mug/mL, most of the newly synthesized compounds displayed 100% inhibitory activity against M. tuberculosis in cellular assays. Further screening allowed the identification of very potent antitubercular agents. Compound 4c was also tested in a time-course experiment and against mtb clinical isolates, displaying interesting results.
PMID: 19620006 [PubMed - as supplied by publisher]
[Tuberculosis Pulmonary]

By mark - Posted on 25 July 2009 Share this

HIV ATLAS

Job Central

Classified Blogs

Event Central

Classified Ads

IEC Central

Videos

Resources

Monthly archive

Latest Jobs (Weekly)

Stay informed on our latest news!

Syndicate content

Classified Resources